Challenges in managing and reporting adverse events in haematological malignancies in low-income and middle-income countries

Affiliations

¹ Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai 400012, India. Electronic address: nayakl@tmc.gov.in.
² Centro de Hematología Pavlovsky, Fundaleu, Buenos Aires, Argentina.
³ Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
⁴ Department of Clinical Oncology, Cancer Diseases Hospital, Lusaka, Zambia.
⁵ Department of Clinical Medicine and Therapeutics, The University of Nairobi, Nairobi, Kenya.
⁶ Federal University of Sao Paulo, Sao Paulo, Brazil.

Lingaraj Nayak et al. Lancet Haematol. 2025 Jun.

. 2025 Jun;12(6):e406-e410.

doi: 10.1016/S2352-3026(25)00141-3.

¹ Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai 400012, India. Electronic address: nayakl@tmc.gov.in.
² Centro de Hematología Pavlovsky, Fundaleu, Buenos Aires, Argentina.
³ Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
⁴ Department of Clinical Oncology, Cancer Diseases Hospital, Lusaka, Zambia.
⁵ Department of Clinical Medicine and Therapeutics, The University of Nairobi, Nairobi, Kenya.
⁶ Federal University of Sao Paulo, Sao Paulo, Brazil.

No abstract available

Comment in

Beyond maximum grade: introduction to The Lancet Haematology Adverse Events Reporting Series.
Thanarajasingam G, Major A, Bhatnagar V, Dueck AC, Smedby KE, El-Galaly TC, Geissler J, Habermann T, Kluetz PG, Seymour JF, Tzogani K, Villa D, Bröckelmann PJ. Thanarajasingam G, et al. Lancet Haematol. 2025 Jun;12(6):e403-e406. doi: 10.1016/S2352-3026(25)00027-4. Lancet Haematol. 2025. PMID: 40447347 No abstract available.